Streamlining regulatory processes for health researchers: To what extent does POPIA apply?

S Afr Med J

Junior Researcher, Sydney Brenner Institute of Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Published: August 2023

Personal information in health research commands utmost protection while also preserving the growth of health research. This paper aims to establish which legislation applies when processing personal information for health research. South Africa regulates health research on human subjects through a network of Human Research Ethics Committees. The Protection of Personal Information Act No. 4 of 2013 (POPIA)  has recently come into force. Section 2(3)(b) of POPIA provides that POPIA does not apply where other legislation creates 'more extensive' conditions for the lawful processing of personal information than Chapter 3 of POPIA does. We show that the provisions of the sectoral legislation on health are more extensive than the conditions in Chapter 3 of POPIA and hence the sectoral legislation prevails. This simplifies the regulation of health research. One of the implications of this finding is that the definition of broad consent in the sectoral legislation for health research should be applied to the exclusion of the consent provisions in POPIA.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11086638PMC
http://dx.doi.org/10.7196/SAMJ.2023.v113i8.781DOI Listing

Publication Analysis

Top Keywords

sectoral legislation
12
health
8
personal health
8
processing personal
8
chapter popia
8
legislation health
8
popia
7
legislation
5
streamlining regulatory
4
regulatory processes
4

Similar Publications

Background: Behaviour support plans (BSPs) for people in residential aged care (RAC) were mandated nationally in 2019 for those who require, or may require, restrictive practices as part of their care. The legislation aims to reduce and potentially eliminate restrictive practices: long-standing problems of their inappropriate use were highlighted by the Royal Commission into Aged Care Quality and Safety (2018). Many people living with dementia will be impacted: up to 90% experience changed behaviours; 54% of people in RACs have dementia; and approximately 20% experience cognitive decline without a diagnosis.

View Article and Find Full Text PDF

[Expert consensus on ethical requirements for artificial intelligence (AI) processing medical data].

Sheng Li Xue Bao

December 2024

Virtual Simulation and Artificial Intelligence Committee, Chinese Association for Physiological Sciences.

As artificial intelligence technology rapidly advances, its deployment within the medical sector presents substantial ethical challenges. Consequently, it becomes crucial to create a standardized, transparent, and secure framework for processing medical data. This includes setting the ethical boundaries for medical artificial intelligence and safeguarding both patient rights and data integrity.

View Article and Find Full Text PDF

Artificial Intelligence (AI) and AI-driven technologies are transforming industries across the board, with the pharmaceutical sector emerging as a frontrunner beneficiary. This article explores the growing impact of AI and Machine Learning (ML) within pharmaceutical Regulatory Affairs, particularly in dossier preparation, compilation, documentation, submission, review, and regulatory compliance. By automating time-intensive tasks, these technologies streamline workflows, accelerate result generation, and shorten the product approval timeline.

View Article and Find Full Text PDF

Compliance with EU legislation on the efficient use of fossil fuels and the reduction in emissions and environmental impact has led many sectors of industry to become interested in obtaining and using more sustainable polymer composites with improved lifetime, in the recovery and recycling of materials at the end of their life cycle, and in the use of renewable natural resources [...

View Article and Find Full Text PDF

Medicare Advantage (MA) plans report diagnoses more completely than they are reported in traditional Medicare. As a result, payment to MA plans is greater than it would be if coding patterns were identical in the two sectors. The Medicare Payment Advisory Commission estimates that the overpayment to MA attributable to differential coding was $50 billion in 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!